Trial intelligence / Profile preview

Clinical trial of KIB-PCI in healthy Japanese children

jRCT2080222503Phase 3

Sponsor
Daiichi Sankyo Co., Ltd.
Start
May 2014
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3 trial of KIB-PCI in influenza, sponsored by Daiichi Sankyo Co., Ltd.

02

Drugs

KIB-PCI
03

Conditions

influenza

Beyond the preview

Go deeper on jRCT2080222503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call